Tenalisib (RP6530)
CAS: 1639417-53-0
Rif. 3D-PQC41753
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Informazioni sul prodotto
Tenalisib is a protein inhibitor that blocks the protein kinase activity of the m2 phenotype. It has been shown to be clinically effective in treating primary T-cell lymphomas, skin cancer, and cancers of the hematopoietic system. Tenalisib inhibits the growth of cancer cells by blocking the transcriptional regulation of genes that promote cell proliferation and survival. Tenalisib is also a chemotherapeutic treatment for human macrophages and hematopoietic cells. The drug has also shown anti-tumor effects in mice with skin cancer as well as antitumor effects on human myeloid-derived suppressor cells. Tenalisib is metabolized by cytochrome P450 enzymes, which are found in high concentrations in hepatic tissue.
Proprietà chimiche
Richiesta tecnica su: 3D-PQC41753 Tenalisib (RP6530)
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
